Are we AKT-ually getting closer to making targeted therapy successful in breast cancer brain metastases?

Neuro Oncol. 2019 Nov 4;21(11):1344-1345. doi: 10.1093/neuonc/noz177.

Authors

Nazanin Majd¹, Shiao-Pei Weathers¹, John de Groot¹

Affiliation

¹ Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center.

No abstract available

Publication types

Comment

MeSH terms

Brain Neoplasms*
Breast Neoplasms*
Class I Phosphatidylinositol 3-Kinases
Humans
Phosphatidylinositol 3-Kinases
Piperazines
Proto-Oncogene Proteins c-akt
Pyrimidines
TOR Serine-Threonine Kinases

Substances

Piperazines
Pyrimidines
ipatasertib
MTOR protein, human
Class I Phosphatidylinositol 3-Kinases
PIK3CA protein, human
Proto-Oncogene Proteins c-akt
TOR Serine-Threonine Kinases